| Date Filed | Type | Description |
| 03/27/2023 |
4
| Hwang Kuk Hyoun (CEO) has filed a Form 4 on Bellevue Life Sciences Acquisition Corp.|
Txns:
| Acquired 20,000 shares
@ $0
Disposed of 20,000 options to buy
@ $11.5, valued at
$230k
|
|
| 03/27/2023 |
4
| Yoo David Jin (CFO) has filed a Form 4 on Bellevue Life Sciences Acquisition Corp.|
Txns:
| Granted 20,000 shares
@ $0
Granted 20,000 options to buy
@ $11.5, valued at
$230k
|
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2023 |
4
| Hwang Kuk Hyoun (CEO) has filed a Form 4 on Bellevue Life Sciences Acquisition Corp.|
Txns:
| Acquired 225,000 shares
@ $0
Disposed of 4,500 shares
@ $0 |
|
| 02/23/2023 |
4
| Bellevue Global Life Science Investors LLC (10% Owner) has filed a Form 4 on Bellevue Life Sciences Acquisition Corp.|
Txns:
| Acquired 225,000 shares
@ $0
Disposed of 4,500 shares
@ $0 |
|
| 02/09/2023 |
3
| Chung In Chul (Director Nominee) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| Roberts Rad (Director Nominee) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| Yoo David Jin (CFO) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| Euh Hosun (Director Nominee) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| Bellevue Global Life Science Investors LLC (10% Owner) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| REED STEVEN (Director Nominee) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| Park Jin Whan (Director Nominee) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| Whang Jun Chul (Director) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| Hwang Kuk Hyoun (See Remarks) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |